ENTITY
China Traditional Chinese Medicine

China Traditional Chinese Medicine (570 HK)

291
Analysis
Health CareHong Kong
China Traditional Chinese Medicine Co. Limited, through its subsidiaries, manufactures and sells medicine and pharmaceutical products in China.
more
21 Jan 2025 00:55

China TCM (570.HK) - About the Profit Warning and the Valuation Outlook

​China TCM's performance decline in 2024 aligns with expectations, but there is hope for future profit growth based on new management. Focus on...

Logo
678 Views
Share
08 Dec 2024 01:43

China Healthcare Weekly (Dec.8) - TCM VBP Update, GLP-1's Good Story Broke, China TCM's Sudden Rally

​Hubei's TCM patent medicine VBP will impact Shineway's performance. Caution needed on GLP-1 market outlook. There's no evidence to support CNPGC’s...

Logo
448 Views
Share
21 Oct 2024 06:22

TCM (570 HK): Likely Rush for The Exits As Deal Busts

How does a ~34% decline (in the morning session) stack up with past deal breaks in Hong Kong? It's not a clean comparative analysis, as past...

Logo
1.2k Views
Share
18 Oct 2024 15:12

China Traditional Chinese Medicine (570 HK): Disaster as Offer Lapses, Potential Deal Break Price

This deal break caught many, including me, off guard. There are lessons to be learnt and questions to be asked. Shareholders will have a bruising...

Logo
1.2k Views
Share
05 Nov 2024 00:55

China TCM (570.HK) Update - The Real Reason For the Deal Break and the Valuation Outlook

​China TCM's decision to abandon privatization may be due to national security concerns. We lowered 2024 forecast. Valuation rebound rely on...

Logo
704 Views
Share
x